Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01649947
Title Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Rutgers, The State University of New Jersey
Indications

lung non-small cell carcinoma

Therapies

Bevacizumab + Carboplatin + Hydroxychloroquine + Paclitaxel

Carboplatin + Hydroxychloroquine + Paclitaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.